Clinic
Adu-Gyamfi and Company INC
Adu-Gyamfi and Company INC was paid $670K by Medicaid between Mar 2018 and Dec 2024, across 52 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoADU-GYAMFI AND COMPANY INC
HOUSTON, TX 77093
HOUSTON, TX 77093
33aNPI1356490882assigned 01/10/2007
33bProvider typeClinic/Center
28Total paid$670K
24GClaims30,036
24DCodes billed52
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Texas
Rank by total paid#35 of 176
Median peer was paid$26K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 131 | $6K | |
| 2019 | 13 | $569.05 | |
| 2020 | 1,419 | $25K | |
| 2021 | 7,849 | $192K | |
| 2022 | 8,321 | $206K | |
| 2023 | 5,877 | $134K | |
| 2024incomplete | 6,426 | $105K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 5,107 | 4,703 | $160K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 3,136 | 2,856 | $133K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 17% | 1,312 | 1,272 | $113K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 15% | 1,250 | 1,209 | $99K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.6% | 507 | 492 | $38K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 5.4% | 544 | 522 | $36K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.8% | 2,486 | 2,380 | $26K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.5% | 2,744 | 1,459 | $24K |
| 99384 | 1.7% | 124 | 123 | $12K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 590 | 294 | $8K |
| 99444 | <1% | 87 | 24 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 350 | 334 | $4K |
40 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 181 | $4K |
| 99383 | <1% | 29 | $2K | |
| 96160 | <1% | 2,065 | $2K | |
| 99385 | <1% | 27 | $2K | |
| 82947 | <1% | 239 | $735.57 | |
| 81003 | <1% | 406 | $706.12 | |
| 0011A | <1% | 19 | $550.40 | |
| 0012A | <1% | 15 | $520.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 12 | $468.24 |
| 97802 | <1% | 3,809 | $3.48 | |
| 90658 | <1% | 546 | $0.70 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 547 | $0.56 |
| 90651 | <1% | 523 | $0.27 | |
| 90620 | <1% | 145 | $0.14 | |
| 90734 | <1% | 518 | $0.09 | |
| 90623 | <1% | 14 | $0.05 | |
| 90715 | <1% | 304 | $0.05 | |
| 91301 | <1% | 81 | $0.05 | |
| 90650 | <1% | 32 | $0.02 | |
| 90633 | <1% | 141 | $0.01 | |
| 1160F | 0% | 134 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 198 | $0.00 |
| 90670 | 0% | 79 | $0.00 | |
| 90648 | 0% | 41 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 53 | $0.00 |
| 3078F | 0% | 174 | $0.00 | |
| 90710 | 0% | 134 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 13 | $0.00 |
| 90707 | 0% | 20 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 95 | $0.00 |
| 1159F | 0% | 148 | $0.00 | |
| 3074F | 0% | 175 | $0.00 | |
| 3008F | 0% | 233 | $0.00 | |
| 90696 | 0% | 89 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 371 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 102 | $0.00 |
| 1036F | 0% | 41 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 16 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 17 | $0.00 |
| 90723 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialADU-GYAMFI, KWAME (DIRECTOR)